15 Jul 2021
|PharmAbcine, non-confidential slide deck July, 2021
PharmAbcine, non-confidential slide deck July, 2021
Notice of Changes:
- New investment thesis slides have been added to help our investors understand the current situation in terms of our share prices.
- The slides about our core pipelines have been modified to focus on new updates.
- All our preclinical models such as PMC-403, PMC-402, and PMC-309 entered GLP-Tox studies which are needed to evaluate the safety of molecules before initiating clinical trials. The finalized data packages are expected to be released next year.
Thank you for your continued support.
Please check the attached file for details.